Anti-MERS-CoV Convalescent Plasma Therapy
NCT02190799
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Respiratory Distress Syndrome (& [Hyaline Membrane Disease])
Interventions
BIOLOGICAL:
Convalescent plasma
Sponsor
King Abdullah International Medical Research Center